dinoprost tromethamine,
Lutalyse,
Minprostin F2 Alpha,
PGF2alpha tromethamine,
prostaglandin F2alpha tromethamine,
Prostin F2,
Prostin F2 Alpha,
dinoprost tromethamine,
Dinolytic,
PGF2-alpha tham,
Zinoprost,
Dinoprost trometamol,
Prostalmon F,
Prostin F2 alpha,
Lutalyse,
38562-01-5,
PGF2alpha THAM,
Pronalgon F,
Prostaglandin F2alpha tham,
Panacelan F tromethamine salt,
Prostaglandin F2-alpha THAM,
Prostaglandin F2a tromethamine,
Dinoprost, trometamol salt,
THAM PGF2-alpha,
Ensaprost,
Lutalyse (Veterinary),
PGF2-alpha tris salt,
PGF2-alpha tromethamine,
Enzaprost F compd. with trisamine,
PGF2-alpha tromethamine salt,
Protaglandin F2-alpha-tham salt,
Prostaglandin F2-alpha THAM salt,
Prostaglandin F2-alpha tromethamine,
Tromethamine prostaglandin F2-alpha,
UNII-CT6BBQ5A68,
Prostaglandin F(sub 2a) tromethamine,
Dinoprost (tromethamine salt),
U-14,583E,
C20H34O5.C4H11NO3,
EINECS 254-002-3,
Prostamate,
U 14585,
NSC 196515,
CT6BBQ5A68,
MLS000028821,
CHEBI:31502,
5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl)-, tham,
7-(3,5-Dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl)-5-heptenoic acid, tromethamine salt,
(E,Z)-(1R,2R,3R,5S)-7-(3,5-Dihydroxy-2-((3S)-(3-hydroxy-1-octenyl))cyclopentyl)-5-heptenoic acid compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1),
SMR000058792,
Prostaglandin F2|A,
1,3-Propanediol, 2-amino-2-(hydroxymethyl)-, (5Z,9alpha,11alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oate (salt),
Prosta-5,13-dien-1-oic acid, (5Z,9-alpha,11-alpha,13E,15S)-9,11,15-trihydroxy-, compd. with trimethylolaminomethane,
Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9alpha,11alpha,13E,15S)-, compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1),
PGF2alpha-Tris,
2-amino-2-(hydroxymethyl)propane-1,3-diol; (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid,
PGF2alpha tromethamine,
Prostaglandin F2a tris salt,
Dinoprost tromethamine [USAN:JAN],
Prostin F2 alpha (TN),
Dinoprost Tromethamine Salt,
prostaglandin F2alpha tromethamine,
Dinoprost tromethamine (JAN/USP),
Prostaglandin F2?,
2-amino-2-(hydroxymethyl)propane-1,3-diol;(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid,
glandin; tris buffer,
dinoprost-tromethamine,
PROSTAGLANDIN F2ALPHA TRIS SALT,
Dinoprost tromethamine [USAN:USP:JAN],
PGF2.alpha. THAM,
PGF2ALPHA-THAM,
Prostaglandin F-2alpha tromethamine salt,
ProstaglandinF2atrissalt,
U-14583E,
Opera_ID_1888,
7-[3, tromethamine salt,
SCHEMBL203377,
Prostaglandin F2.alpha. THAM,
AC1NR011,
CHEMBL1200896,
REGID_for_CID_5282415,
HMS2230J05,
AN-110,
HY-12956A,
MFCD00077863,
NSC196515,
Prostaglandin F(2)(alpha) tris salt,
AKOS015920234,
AT-5102,
DB01160,
NSC-196515,
RP17760,
(5Z,9alpha,11alpha,13E,15S)-9,11,15-Trihydroxyprosta-5,13-dienoic acid tris salt,
Prostin F2 alpha,3-propanediol (1:1),
BR-72816,
CC-27068,
Prosta-5,13-dien-1-oic acid, (5Z,9-alpha,11-alpha,13E,15S)-9,11,15-trihydroxy-,compd. with trimethylolaminomethane,
Prostaglandin F2alpha (tromethamine salt),
U-14,
LS-125841,
B7617,
C12786,
D01352,
Prostaglandin F2.alpha.,3-propanediol (1:1),
562D015,
562P015,
SR-01000946463,
SR-01000946463-1,
WLN: L5TJ AQ B2U4VQ C1U1YQ5 DQ &Q1XZ1Q1Q,
Prostaglandin F2alpha tris salt, >=99%, synthetic, powder,
Prostaglandin F2alpha tris salt, synthetic, cell culture tested,
Dinoprost trometamol, European Pharmacopoeia (EP) Reference Standard,
5-Heptenoic acid,5-dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl]-, THAM,
Dinoprost compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1),
Dinoprost tromethamine, United States Pharmacopeia (USP) Reference Standard,
9?,11?,15S-Trihydroxy-prosta-5Z,13E-dien-1-oic acid tris(hydroxymethyl)aminomethane salt,
(E,2R,3R,5S)-7-[3,5-Dihydroxy-2-[(3S)-(3-hydroxy-1-octenyl)]cyclopentyl]-5-heptenoic acid compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1)@component of Prostin F2 Alpha, injectable,
Prosta-5, (5Z,9.alpha.,11.alpha.,13E,15S)-9,11,15-trihydroxy- compd. with (trimethylolamino)methane,
Prosta-5, 9,11,15-trihydroxy-, (5Z,9.alpha.,11.alpha.,13E,15S)-, compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1),
prostaglandin F2alpha,
Dinoprosttromethamine,
D04RGA,
Prostaglandin F2? tris salt,
MLS003107056,
CID5282415,
CS-4233,
583E,
2-Amino-2-(hydroxymethyl)propane-1,3-diol,
C20-H34-O5.C4-H11-N-O3,
U 14583,
(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid,
Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9.alpha.,11.alpha.,13E,15S)-, compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1),
Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9.alpha.,11.alpha.,13E,15S)-, compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1),
Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9?,11?,13E,15S)-, compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1),